Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Nootropics / Cholinergics

69 In the index

Galantamine GALA

An FDA-approved Alzheimer's medication that also affects a receptor involved in dreaming, making it popular off-label among people trying to have lucid dreams. Its Alzheimer's benefits are backed by real studies; the lucid-dreaming use rests mainly on personal reports rather than dedicated research.

Also known as Razadyne

Effects Focus Sleep
Routes Oral
Legal status Prescription drug
WADA Not listed

3D Molecular Structure of C17H21NO3

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Nitrogen
  • Oxygen

Chemistry

Formula
C17H21NO3
Molar mass
287.35
CAS
357-70-0
PubChem CID
9651

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 8 mg/day
Reported range 8-24 mg/day (Alzheimer's); 4-8 mg taken before bed for lucid-dreaming use
Route Oral
Frequency Once or twice daily
Duration Chronic/ongoing (Alzheimer's) or occasional (lucid-dreaming use)

FDA-approved (Razadyne) for Alzheimer's disease; also popular off-label in low doses among recreational 'lucid dreaming' communities.

Where this comes from FDA prescribing information; off-label user-reported dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.